GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹752 Cr | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹752 Cr |
| Mar2025 | ₹2,186 Cr |
| Mar2024 | ₹-1,560 Cr |
| Mar2023 | ₹1,587 Cr |
| Mar2022 | ₹-177 Cr |
How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹752 Cr | -65.59 | |
| Mar2025 | ₹2,186 Cr | Positive | |
| Mar2024 | ₹-1,560 Cr | Negative | |
| Mar2023 | ₹1,587 Cr | Positive | |
| Mar2022 | ₹-177 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹52,102.1 Cr | 2.7% | 8.4% | 66% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.7% |
8.4% |
66% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses